Trademark Attorney / Law Firm
Bryan C. Reuter – Trademark Portfolio
Bryan C. Reuter specializes in Class 36 (Insurance & Financial) trademark filings before the United States Patent and Trademark Office (USPTO), with 5 of 9 total filings concentrated in this category. The practice also covers Class 30 (Staple Foods) along with 4 other Nice Classification classes. Filing activity spans from 2006 to 2016. Currently, 0 trademarks are registered.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
Bryan C. Reuter's trademark practice covers 4 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Insurance; financial affairs; monetary affairs; real estate affairs
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademark applications has Bryan C. Reuter filed?
Bryan C. Reuter has filed 9 trademark applications with the United States Patent and Trademark Office (USPTO).
What trademark classes does Bryan C. Reuter specialize in?
Bryan C. Reuter has filed trademarks across 4 Nice Classification classes. The most common practice areas include Class 36 (Insurance & Financial), Class 30 (Staple Foods), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
How long has Bryan C. Reuter been filing trademarks?
Bryan C. Reuter's trademark filing history with the USPTO spans from 2006 to 2016, covering 10 years of trademark practice. During this period, Bryan C. Reuter has handled 9 trademark applications.
What is Bryan C. Reuter's trademark registration success rate?
Bryan C. Reuter has a 0% trademark registration rate, with 0 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.